Emerin in health and disease

Seminars in Cell and Developmental Biology

Volumn 29, Issue , 2014, Pages 95-106

  Koch, Adam J ^a   Holaska, James M ^a  

^a UNIVERSITY OF CHICAGO   (United States)

Author keywords

Emerin; Emery Dreifuss muscular dystrophy; Lamina; Laminopathies; Lamins A C; Nuclear envelope

Indexed keywords

ACTIN; BARRIER TO AUTOINTEGRATION FACTOR; BETA CATENIN; BIOLOGICAL FACTOR; EMERIN; LAMIN; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR IIH; TRANSCRIPTION FACTOR LMO7; UNCLASSIFIED DRUG; BANF1 PROTEIN, HUMAN; BCLAF1 PROTEIN, HUMAN; DNA BINDING PROTEIN; FHL1 PROTEIN, HUMAN; LAMIN A; LIM PROTEIN; LMNA PROTEIN, HUMAN; LMO7 PROTEIN, HUMAN; MEMBRANE PROTEIN; MUSCLE PROTEIN; NUCLEAR PROTEIN; REPRESSOR PROTEIN; SIGNAL PEPTIDE; TUMOR SUPPRESSOR PROTEIN;

CELL NUCLEUS MEMBRANE; CHROMATIN; EMERY DREIFUSS MUSCULAR DYSTROPHY; GENE EXPRESSION; GENE MUTATION; GERM CELL; HUMAN; MUSCLE REGENERATION; NUCLEAR LAMINA; NUCLEAR MEDICINE; PHENOTYPE; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PROCESSING; REVIEW; ANIMAL; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; MOUSE; MUTATION; PHYSIOLOGY; SIGNAL TRANSDUCTION;

ANIMALS; BETA CATENIN; DNA-BINDING PROTEINS; GENE EXPRESSION REGULATION, DEVELOPMENTAL; HUMANS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; LAMIN TYPE A; LIM DOMAIN PROTEINS; MEMBRANE PROTEINS; MICE; MUSCLE PROTEINS; MUSCULAR DYSTROPHY, EMERY-DREIFUSS; MUTATION; NUCLEAR LAMINA; NUCLEAR PROTEINS; REPRESSOR PROTEINS; SIGNAL TRANSDUCTION; TRANSCRIPTION FACTORS; TUMOR SUPPRESSOR PROTEINS;

EID: 84901640474     PISSN: 10849521     EISSN: 10963634     Source Type: Journal    
DOI: 10.1016/j.semcdb.2013.12.008     Document Type: Review

References (225)

1. Raffaele di Barletta M., Ricci E., Galluzzi G., Tonali P., Mora M., Morandi L., et al. Different mutations in the LMNA gene cause autosomal dominant and autosomal recessive Emery-Dreifuss muscular dystrophy. Am J Hum Genet 2000, 66:1407-1412.
2. Jimenez-Escrig A., Gobernado I., Garcia-Villanueva M., Sanchez-Herranz A. Autosomal recessive Emery-Dreifuss muscular dystrophy caused by a novel mutation (R225Q) in the lamin A/C gene identified by exome sequencing. Muscle Nerve 2012, 45:605-610.
3. Helbling-Leclerc A., Bonne G., Schwartz K. Emery-Dreifuss muscular dystrophy. Eur J Hum Genet 2002, 10:157-161.
4. Emery A.E. Emery-Dreifuss muscular dystrophy - a 40 year retrospective. Neuromuscul Disord 2000, 10:228-232.
5. Bione S., Maestrini E., Rivella S., Mancini M., Regis S., Romeo G., et al. Identification of a novel X-linked gene responsible for Emery-Dreifuss muscular dystrophy. Nat Genet 1994, 8:323-327.
6. Bonne G., Di Barletta M.R., Varnous S., Bécane H.M., Hammouda E.H., Merlini L., et al. Mutations in the gene encoding lamin A/C cause autosomal dominant Emery-Dreifuss muscular dystrophy. Nat Genet 1999, 21:285-288.
7. Zhang Q., Bethmann C., Worth N.F., Davies J.D., Wasner C., Feuer A., et al. Nesprin-1 and -2 are involved in the pathogenesis of Emery Dreifuss muscular dystrophy and are critical for nuclear envelope integrity. Hum Mol Genet 2007, 16:2816-2833.
8. Liang W.-C., Mitsuhashi H., Keduka E., Nonaka I., Noguchi S., Nishino I., et al. TMEM43 mutations in Emery-Dreifuss muscular dystrophy-related myopathy. Ann Neurol 2011, 69:1005-1013.
9. Gueneau L., Bertrand A.T., Jais J.-P., Salih M.A., Stojkovic T., Wehnert M., et al. Mutations of the FHL1 gene cause Emery-Dreifuss muscular dystrophy. Am J Hum Genet 2009, 85:338-353.
10. Méndez-López I., Worman H.J. Inner nuclear membrane proteins: impact on human disease. Chromosoma 2012.
11. Burke B., Stewart C.L. The laminopathies: the functional architecture of the nucleus and its contribution to disease. Annu Rev Genomics Hum Genet 2006, 7:369-405.
12. Vlcek S. Current opinion in cell biology: lamins and lamin-associated proteins in aging and disease. Curr Opin Cell Biol 2007, 19:298-304.
13. Worman H.J. Nuclear lamins and laminopathies. J Pathol 2011, 226:316-325.
14. Emery A.E. Emery-Dreifuss syndrome. J Med Genet 1989, 26:637-641.
15. Bonne G., Mercuri E., Muchir A., Urtizberea A., Bécane H.M., Recan D., et al. Clinical and molecular genetic spectrum of autosomal dominant Emery-Dreifuss muscular dystrophy due to mutations of the lamin A/C gene. Ann Neurol 2000, 48:170-180.
16. Bonne G., Capeau J., De Visser M., Duboc D., Merlini L., Morris G.E., et al. 82nd ENMC international workshop, 5th international Emery-Dreifuss muscular dystrophy (EDMD) workshop, 1st Workshop of the MYO-CLUSTER project EUROMEN (European muscle envelope nucleopathies), 15-16 September 2000, Naarden, The Netherlands. Neuromuscul Disord 2002, 12:187-194.
17. Muchir A., Worman H.J. Emery-Dreifuss muscular dystrophy. Curr Neurol Neurosci Rep 2007, 7:78-83.
18. Meune C., Van Berlo J.H., Anselme F., Bonne G., Pinto Y.M., Duboc D. Primary prevention of sudden death in patients with lamin A/C gene mutations. N Engl J Med 2006, 354:209-210.
19. Bonne G., Yaou R.B., Béroud C., Boriani G., Brown S., De Visser M., et al. 108th ENMC international workshop, 3rd workshop of the MYO-CLUSTER project: EUROMEN, 7th international Emery-Dreifuss muscular dystrophy (EDMD) workshop, 13-15 September 2002, Naarden, The Netherlands. Neuromuscul Disord 2003, 13:508-515.
20. Sewry C.A., Brown S.C., Mercuri E., Bonne G., Feng L., Camici G., et al. Skeletal muscle pathology in autosomal dominant Emery-Dreifuss muscular dystrophy with lamin A/C mutations. Neuropathol Appl Neurobiol 2001, 27:281-290.
21. Fidziańska A., Toniolo D., Hausmanowa-Petrusewicz I. Ultrastructural abnormality of sarcolemmal nuclei in Emery-Dreifuss muscular dystrophy (EDMD). J Neurol Sci 1998, 159:88-93.
22. Sabatelli P., Lattanzi G., Ognibene A., Columbaro M., Capanni C., Merlini L., et al. Nuclear alterations in autosomal-dominant Emery-Dreifuss muscular dystrophy. Muscle Nerve 2001, 24:826-829.
23. Fidziańska A., Hausmanowa-Petrusewicz I. Architectural abnormalities in muscle nuclei. Ultrastructural differences between X-linked and autosomal dominant forms of EDMD. J Neurol Sci 2003, 210:47-51.
24. Fidziańska A., Glinka Z. Nuclear architecture remodelling in envelopathies. Folia Neuropathol 2007, 45:47-55.
25. Menezes M.P., Waddell L.B., Evesson F.J., Cooper S., Webster R., Jones K., et al. Importance and challenge of making an early diagnosis in LMNA-related muscular dystrophy. Neurology 2012, 78:1258-1263.
26. Bonne G., Leturcq F., Récan-Budiartha D. Emery-Dreifuss Muscular dystrophy - Conditions - GTR - NCBI 2010, GeneReviews [Internet].
27. Brown C.A., Lanning R.W., McKinney K.Q., Salvino A.R., Cherniske E., Crowe C.A., et al. Novel and recurrent mutations in lamin A/C in patients with Emery-Dreifuss muscular dystrophy. Am J Med Genet 2001, 102:359-367.
28. Vytopil M., Benedetti S., Ricci E., Galluzzi G., Russo Dello A., Merlini L., et al. Mutation analysis of the lamin A/C gene (LMNA) among patients with different cardiomuscular phenotypes. J Med Genet 2003, 40:e132.
29. Morris G.E., Manilal S. Heart to heart: from nuclear proteins to Emery-Dreifuss muscular dystrophy. Hum Mol Genet 1999, 8:1847-1851.
30. Nagano A., Koga R., Ogawa M., Kurano Y., Kawada J. Emerin deficiency at the nuclear membrane in patients with Emery-Dreifuss muscular dystrophy. Nat Genet 1996, 12:254-259.
31. Yates J.R., Bagshaw J., Aksmanovic V.M., Coomber E., McMahon R., Whittaker J.L., et al. Genotype-phenotype analysis in X-linked Emery-Dreifuss muscular dystrophy and identification of a missense mutation associated with a milder phenotype. Neuromuscul Disord 1999, 9:159-165.
32. Bengtsson L., Wilson K.L. Multiple and surprising new functions for emerin, a nuclear membrane protein. Curr Opin Cell Biol 2004, 16:73-79.
33. Bakay M., Wang Z., Melcon G., Schiltz L., Xuan J., Zhao P., et al. Nuclear envelope dystrophies show a transcriptional fingerprint suggesting disruption of Rb-MyoD pathways in muscle regeneration. Brain 2006, 129:996-1013.
34. Melcon G., Kozlov S., Cutler D.A., Sullivan T., Hernandez L., Zhao P., et al. Loss of emerin at the nuclear envelope disrupts the Rb1/E2F and MyoD pathways during muscle regeneration. Hum Mol Genet 2006, 15:637-651.
35. Frock R.L., Kudlow B.A., Evans A.M., Jameson S.A., Hauschka S.D., Kennedy B.K. Lamin A/C and emerin are critical for skeletal muscle satellite cell differentiation. Genes Dev 2006, 20:486-500.
36. Huber M.D., Guan T., Gerace L. Overlapping functions of nuclear envelope proteins NET25 (Lem2) and emerin in regulation of extracellular signal-regulated kinase signaling in myoblast differentiation. Mol Cell Biol 2009, 29:5718-5728.
37. Massagué J., Cheifetz S., Endo T., Nadal-Ginard B. Type beta transforming growth factor is an inhibitor of myogenic differentiation. Proc Natl Acad Sci USA 1986, 83:8206-8210.
38. Koch A.J., Holaska J.M. Loss of emerin alters myogenic signaling and miRNA expression in mouse myogenic progenitors. PLoS ONE 2012, 7:e37262.
39. Polesskaya A., Seale P., Rudnicki M.A. Wnt signaling induces the myogenic specification of resident CD45+ adult stem cells during muscle regeneration. Cell 2003, 113:841-852.
40. Ridgeway A.G. Wnt signaling regulates the function of MyoD and myogenin. J Biol Chem 2000, 275:32398-32405.
41. Conboy I.M., Rando T.A. The regulation of Notch signaling controls satellite cell activation and cell fate determination in postnatal myogenesis. Dev Cell 2002, 3:397-409.
42. Edwall D., Schalling M., Jennische E., Norstedt G. Induction of insulin-like growth factor I messenger ribonucleic acid during regeneration of rat skeletal muscle. Endocrinology 1989, 124:820-825.
43. Jennische E., Hansson H.A. Regenerating skeletal muscle cells express insulin-like growth factor I. Acta Physiol Scand 1987, 130:327-332.
44. Karalaki M., Fili S., Philippou A., Koutsilieris M. Muscle regeneration: cellular and molecular events. In Vivo 2009, 23:779-796.
45. Zammit P.S., Partridge T.A., Yablonka-Reuveni Z. The skeletal muscle satellite cell: the stem cell that came in from the cold. J Histochem Cytochem 2006, 54:1177-1191.
46. Kuang S., Gillespie M.A., Rudnicki M.A. Niche regulation of muscle satellite cell self-renewal and differentiation. Cell Stem Cell 2008, 2:22-31.
47. Rudnicki M.A., Le Grand F., McKinnell I., Kuang S. The molecular regulation of muscle stem cell function. Cold Spring Harb Symp Quant Biol 2009, 73:323-331.
48. Demmerle J., Koch A.J., Holaska J.M. Emerin and histone deacetylase 3 (HDAC3) cooperatively regulate expression and nuclear positions of MyoD, Myf5, and Pax7 genes during myogenesis. Chromosome Res 2013, (epub ahead of print).
49. Simon D.N., Wilson K.L. The nucleoskeleton as a genome-associated dynamic network of networks. Nat Rev Mol Cell Biol 2011, 12:695-708.
50. Dittmer T.A., Misteli T. The lamin protein family. Genome Biol 2011, 12:222.
51. Burke B., Stewart C.L. The nuclear lamins: flexibility in function. Nat Rev Mol Cell Biol 2012, 14:13-24.
52. Dahl K.N., Kalinowski A. Nucleoskeleton mechanics at a glance. J Cell Sci 2011, 124:675-678.
53. Schirmer E.C. Nuclear membrane proteins with potential disease links found by subtractive proteomics. Science 2003, 301:1380-1382.
54. Wilkie G.S., Korfali N., Swanson S.K., Malik P., Srsen V., Batrakou D.G. Several novel nuclear envelope transmembrane proteins identified in skeletal muscle have cytoskeletal associations. Mol Cell Proteomics 2011, 10. M110.003129.
55. Korfali N., Wilkie G.S., Swanson S.K., Srsen V., Batrakou D.G., Fairley E.A.L., et al. The leukocyte nuclear envelope proteome varies with cell activation and contains novel transmembrane proteins that affect genome architecture. Mol Cell Proteomics 2010, 9:2571-2585.
56. Mattout-Drubezki A., Gruenbaum Y. Dynamic interactions of nuclear lamina proteins with chromatin and transcriptional machinery. Cell Mol Life Sci 2003, 60:2053-2063.
57. Prokocimer M., Davidovich M., Nissim-Rafinia M., Wiesel-Motiuk N., Bar D.Z., Barkan R., et al. Nuclear lamins: key regulators of nuclear structure and activities. J Cell Mol Med 2009, 13:1059-1085.
58. Korfali N., Srsen V., Waterfall M., Batrakou D.G., Pekovic V., Hutchison C.J., et al. A flow cytometry-based screen of nuclear envelope transmembrane proteins identifies NET4/Tmem53 as involved in stress-dependent cell cycle withdrawal. PLoS ONE 2011, 6:e18762.
59. Zuleger N., Boyle S., Kelly D.A., las Heras de J.I., Lazou V., Korfali N., et al. Specific nuclear envelope transmembrane proteins can promote the location of chromosomes to and from the nuclear periphery. Genome Biol 2013, 14:R14.
60. Ellis J.A., Craxton M., Yates J.R., Kendrick-Jones J. Aberrant intracellular targeting and cell cycle-dependent phosphorylation of emerin contribute to the Emery-Dreifuss muscular dystrophy phenotype. J Cell Sci 1998, 111(Pt. 6):781-792.
61. Ostlund C., Ellenberg J., Hallberg E., Lippincott-Schwartz J., Worman H.J. Intracellular trafficking of emerin, the Emery-Dreifuss muscular dystrophy protein. J Cell Sci 1999, 112(Pt. 11):1709-1719.
62. Ostlund C., Sullivan T., Stewart C.L., Worman H.J. Dependence of diffusional mobility of integral inner nuclear membrane proteins on A-type lamins. Biochemistry 2006, 45:1374-1382.
63. Sullivan T., Escalante-Alcalde D., Bhatt H., Anver M., Bhat N., Nagashima K., et al. Loss of A-type lamin expression compromises nuclear envelope integrity leading to muscular dystrophy. J Cell Biol 1999, 147:913-920.
64. Holaska J.M., Wilson K.L., Mansharamani M. The nuclear envelope, lamins and nuclear assembly. Curr Opin Cell Biol 2002, 14:357-364.
65. Manilal S., Nguyen T.M., Sewry C.A., Morris G.E. The Emery-Dreifuss muscular dystrophy protein, emerin, is a nuclear membrane protein. Hum Mol Genet 1996, 5:801-808.
66. Tunnah D., Sewry C.A., Vaux D., Schirmer E.C., Morris G.E. The apparent absence of lamin B1 and emerin in many tissue nuclei is due to epitope masking. J Mol Hist 2005, 36:337-344.
67. Holaska J.M., Wilson K.L. Multiple roles for emerin: implications for Emery-Dreifuss muscular dystrophy. Anat Rec A: Discov Mol Cell Evol Biol 2006, 288:676-680.
68. Wilson K.L., Holaska J.M., Montes de Oca R., Tifft K., Zastrow M., Segura-Totten M., et al. Nuclear membrane protein emerin: roles in gene regulation, actin dynamics and human disease. Novartis Found Symp 2005, 264:51-58. (discussion 58-62, 227-30).
69. Margalit A., Brachner A., Gotzmann J., Foisner R., Gruenbaum Y. Barrier-to-autointegration factor - a BAFfling little protein. Trends Cell Biol 2007, 17:202-208.
70. Segura-Totten M., Wilson K.L. BAF: roles in chromatin, nuclear structure and retrovirus integration. Trends Cell Biol 2004, 14:261-266.
71. Cai M., Huang Y., Ghirlando R., Wilson K.L., Craigie R., Clore G.M. Solution structure of the constant region of nuclear envelope protein LAP2 reveals two LEM-domain structures: one binds BAF and the other binds DNA. EMBO J 2001, 20:4399-4407.
72. Lin F., Blake D.L., Callebaut I., Skerjanc I.S., Holmer L., McBurney M.W., et al. MAN1, an inner nuclear membrane protein that shares the LEM domain with lamina-associated polypeptide 2 and emerin. J Biol Chem 2000, 275:4840-4847.
73. Lee K.K., Haraguchi T., Lee R.S., Koujin T., Hiraoka Y., Wilson K.L. Distinct functional domains in emerin bind lamin A and DNA-bridging protein BAF. J Cell Sci 2001, 114:4567-4573.
74. Brachner A., Foisner R. Evolvement of LEM proteins as chromatin tethers at the nuclear periphery. Biochem Soc Trans 2011, 39:1735-1741.
75. Mans B.J., Anantharaman V., Aravind L., Koonin E.V. Comparative genomics, evolution and origins of the nuclear envelope and nuclear pore complex. Cell Cycle 2004, 3:1612-1637.
76. Wolff N., Gilquin B., Courchay K., Callebaut I., Worman H.J., Zinn-Justin S. Structural analysis of emerin, an inner nuclear membrane protein mutated in X-linked Emery-Dreifuss muscular dystrophy. FEBS Lett 2001, 501:171-176.
77. Tsuchiya Y., Hase A., Ogawa M., Yorifuji H., Arahata K. Distinct regions specify the nuclear membrane targeting of emerin, the responsible protein for Emery-Dreifuss muscular dystrophy. Eur J Biochem 1999, 259:859-865.
78. Holaska J.M. Transcriptional repressor germ cell-less (GCL) and barrier to autointegration factor (BAF) compete for binding to emerin in vitro. J Biol Chem 2002, 278:6969-6975.
79. Haraguchi T., Holaska J.M., Yamane M., Koujin T., Hashiguchi N., Mori C., et al. Emerin binding to Btf, a death-promoting transcriptional repressor, is disrupted by a missense mutation that causes Emery-Dreifuss muscular dystrophy. Eur J Biochem 2004, 271:1035-1045.
80. Holaska J.M., Rais-Bahrami S., Wilson K.L. Lmo7 is an emerin-binding protein that regulates the transcription of emerin and many other muscle-relevant genes. Hum Mol Genet 2006, 15:3459-3472.
81. Markiewicz E., Tilgner K., Barker N., van de Wetering M., Clevers H., Dorobek M., et al. The inner nuclear membrane protein emerin regulates beta-catenin activity by restricting its accumulation in the nucleus. EMBO J 2006, 25:3275-3285.
82. Holaska J.M., Wilson K.L. An emerin proteome: purification of distinct emerin-containing complexes from HeLa cells suggests molecular basis for diverse roles including gene regulation, mRNA splicing, signaling, mechanosensing, and nuclear architecture. Biochemistry 2007, 46:8897-8908.
83. Wilkinson F.L., Holaska J.M., Zhang Z., Sharma A., Manilal S., Holt I., et al. Emerin interacts in vitro with the splicing-associated factor, YT521-B. Eur J Biochem 2003, 270:2459-2466.
84. la Luna de S., Allen K.E., Mason S.L., La Thangue N.B. Integration of a growth-suppressing BTB/POZ domain protein with the DP component of the E2F transcription factor. EMBO J 1999, 18:212-228.
85. Gjerstorff M.F., Ditzel H.J. An overview of the GAGE cancer/testis antigen family with the inclusion of newly identified members. Tissue Antigens 2008, 71:187-192.
86. Gjerstorff M.F., Rösner H.I., Pedersen C.B., Greve K.B.V., Schmidt S., Wilson K.L., et al. GAGE cancer-germline antigens are recruited to the nuclear envelope by germ cell-less (GCL). PLoS ONE 2012, 7:e45819.
87. Rénert A.-F., Leprince P., Dieu M., Renaut J., Raes M., Bours V., et al. The proapoptotic C16-ceramide-dependent pathway requires the death-promoting factor Btf in colon adenocarcinoma cells. J Proteome Res 2009, 8:4810-4822.
88. Kasof G.M., Goyal L., White E. Btf, a novel death-promoting transcriptional repressor that interacts with Bcl-2-related proteins. Mol Cell Biol 1999, 19:4390-4404.
89. Lee Y.Y., Yu Y.B., Gunawardena H.P., Xie L., Chen X. BCLAF1 is a radiation-induced H2AX-interacting partner involved in (H2AX-mediated regulation of apoptosis and DNA repair. Cell Death Dis 2012, 3:e359.
90. Liu H., Lu Z.-G., Miki Y., Yoshida K. Protein kinase C delta induces transcription of the TP53 tumor suppressor gene by controlling death-promoting factor Btf in the apoptotic response to DNA damage. Mol Cell Biol 2007, 27:8480-8491.
91. Merz C., Urlaub H., Will C.L., Lührmann R. Protein composition of human mRNPs spliced in vitro and differential requirements for mRNP protein recruitment. RNA 2007, 13:116-128.
92. Saitoh N. Proteomic analysis of interchromatin granule clusters. Mol Biol Cell 2004, 15:3876-3890.
93. Sarras H., Alizadeh Azami S., McPherson J.P. In search of a function for BCLAF1. Sci World J 2010, 10:1450-1461.
94. McPherson J.P., Sarras H., Lemmers B., Tamblyn L., Migon E., Matysiak-Zablocki E., et al. Essential role for Bclaf1 in lung development and immune system function. Cell Death Differ 2009, 16:331-339.
95. Ooshio T., Irie K., Morimoto K., Fukuhara A., Imai T., Takai Y. Involvement of LMO7 in the association of two cell-cell adhesion molecules, nectin and E-cadherin, through afadin and alpha-actinin in epithelial cells. J Biol Chem 2004, 279:31365-31373.
96. Putilina T., Jaworski C., Gentleman S., McDonald B., Kadiri M., Wong P. Analysis of a human cDNA containing a tissue-specific alternatively spliced LIM domain. Biochem Biophys Res Commun 1998, 252:433-439.
97. Semenova E., Wang X., Jablonski M.M., Levorse J., Tilghman S.M. An engineered 800 kilobase deletion of Uchl3 and Lmo7 on mouse chromosome 14 causes defects in viability, postnatal growth and degeneration of muscle and retina. Hum Mol Genet 2003, 12:1301-1312.
98. Dedeic Z., Cetera M., Cohen T.V., Holaska J.M. Emerin inhibits Lmo7 binding to the Pax3 and MyoD promoters and expression of myoblast proliferation genes. J Cell Sci 2011, 124:1691-1702.
99. Wozniak M.A., Baker B.M., Chen C.S., Wilson K.L. The emerin-binding transcription factor Lmo7 is regulated by association with p130Cas at focal adhesions. PeerJ 2013, 1:e134.
100. Tilgner K., Wojciechowicz K., Jahoda C., Hutchison C., Markiewicz E. Dynamic complexes of A-type lamins and emerin influence adipogenic capacity of the cell via nucleocytoplasmic distribution of beta-catenin. J Cell Sci 2009, 122:401-413.
101. Otto A., Schmidt C., Luke G., Allen S., Valasek P., Muntoni F., et al. Canonical Wnt signalling induces satellite-cell proliferation during adult skeletal muscle regeneration. J Cell Sci 2008, 121:2939-2950.
102. Brack A.S., Conboy I.M., Conboy M.J., Shen J., Rando T.A. A temporal switch from notch to Wnt signaling in muscle stem cells is necessary for normal adult myogenesis. Cell Stem Cell 2008, 2:50-59.
103. Furukawa K., Sugiyama S., Osouda S., Goto H., Inagaki M., Horigome T., et al. Barrier-to-autointegration factor plays crucial roles in cell cycle progression and nuclear organization in Drosophila. J Cell Sci 2003, 116:3811-3823.
104. Haraguchi T., Koujin T., Osakada H., Kojidani T., Mori C., Masuda H., et al. Nuclear localization of barrier-to-autointegration factor is correlated with progression of S phase in human cells. J Cell Sci 2007, 120:1967-1977.
105. Dabauvalle M.C., Müller E., Ewald A., Kress W. Distribution of emerin during the cell cycle. Eur J Cell Biol 1999, 78:749-756.
106. Haraguchi T., Kojidani T., Koujin T., Shimi T., Osakada H., Mori C., et al. Live cell imaging and electron microscopy reveal dynamic processes of BAF-directed nuclear envelope assembly. J Cell Sci 2008, 121:2540-2554.
107. Haraguchi T., Koujin T., Segura-Totten M., Lee K.K., Matsuoka Y., Yoneda Y., et al. BAF is required for emerin assembly into the reforming nuclear envelope. J Cell Sci 2001, 114:4575-4585.
108. Montes de Oca R., Shoemaker C.J., Gucek M., Cole R.N., Wilson K.L. Barrier-to-autointegration factor proteome reveals chromatin-regulatory partners. PLoS ONE 2009, 4:e7050.
109. Skoko D., Li M., Huang Y., Mizuuchi M., Cai M., Bradley C.M., et al. Barrier-to-autointegration factor (BAF) condenses DNA by looping. Proc Natl Acad Sci USA 2009, 106:16610-16615.
110. Wang X., Xu S., Rivolta C., Li L.Y., Peng G.-H., Swain P.K., et al. Barrier to autointegration factor interacts with the cone-rod homeobox and represses its transactivation function. J Biol Chem 2002, 277:43288-43300.
111. Montes de Oca R., Andreassen P.R., Wilson K.L. Barrier-to-autointegration factor influences specific histone modifications. Nucleus (Austin, TX) 2011, 2:580-590.
112. Shumaker D.K., Lee K.K., Tanhehco Y.C., Craigie R., Wilson K.L. LAP2 binds to BAF. DNA complexes: requirement for the LEM domain and modulation by variable regions. EMBO J 2001, 20:1754-1764.
113. Puente X.S., Quesada V., Osorio F.G., Cabanillas R., Cadiñanos J., Fraile J.M., et al. Exome sequencing and functional analysis identifies BANF1 mutation as the cause of a hereditary progeroid syndrome. Am J Hum Genet 2011, 88:650-656.
114. Cabanillas R., Cadiñanos J., Villameytide J.A.F., Pérez M., Longo J., Richard J.M., et al. Néstor-Guillermo progeria syndrome: a novel premature aging condition with early onset and chronic development caused by BANF1 mutations. Am J Med Genet 2011, 155:2617-2625.
115. Dittrich C.M., Kratz K., Sendoel A., Gruenbaum Y., Jiricny J., Hengartner M.O. LEM-3 - a LEM domain containing nuclease involved in the DNA damage response in C. elegans. PLoS ONE 2012, 7:e24555.
116. Berk J.M., Tifft K.E., Wilson K.L. The nuclear envelope LEM-domain protein emerin. Nucleus 2013, 4:298-314.
117. Manju K., Muralikrishna B., Parnaik V.K. Expression of disease-causing lamin A mutants impairs the formation of DNA repair foci. J Cell Sci 2006, 119:2704-2714.
118. Ozawa R., Hayashi Y.K., Ogawa M., Kurokawa R., Matsumoto H., Noguchi S., et al. Emerin-lacking mice show minimal motor and cardiac dysfunctions with nuclear-associated vacuoles. Am J Pathol 2006, 168:907-917.
119. Muchir A., Pavlidis P., Bonne G., Hayashi Y.K., Worman H.J. Activation of MAPK in hearts of EMD null mice: similarities between mouse models of X-linked and autosomal dominant Emery Dreifuss muscular dystrophy. Hum Mol Genet 2007, 16:1884-1895.
120. Muchir A., Wu W., Worman H.J. Reduced expression of A-type lamins and emerin activates extracellular signal-regulated kinase in cultured cells. BBA - Mol Basis Dis 2008, 1792:75-81.
121. Worman H.J., Fong L.G., Muchir A., Young S.G. Laminopathies and the long strange trip from basic cell biology to therapy. J Clin Invest 2009, 119:1825-1836.
122. Muchir A., Shan J., Bonne G., Lehnart S.E., Worman H.J. Inhibition of extracellular signal-regulated kinase signaling to prevent cardiomyopathy caused by mutation in the gene encoding A-type lamins. Hum Mol Genet 2009, 18:241-247.
123. Rowat A.C., Lammerding J., Ipsen J.H. Mechanical properties of the cell nucleus and the effect of emerin deficiency. Biophys J 2006, 91:4649-4664.
124. Lammerding J. Abnormal nuclear shape and impaired mechanotransduction in emerin-deficient cells. J Cell Biol 2005, 170:781-791.
125. Lammerding J., Schulze P.C., Takahashi T., Kozlov S., Sullivan T., Kamm R.D., et al. Lamin A/C deficiency causes defective nuclear mechanics and mechanotransduction. J Clin Invest 2004, 113:370-378.
126. Olson E.N., Nordheim A. Linking actin dynamics and gene transcription to drive cellular motile functions. Nat Rev Mol Cell Biol 2010, 11:353-365.
127. Ho C.Y., Jaalouk D.E., Vartiainen M.K., Lammerding J. Lamin A/C and emerin regulate MKL1-SRF activity by modulating actin dynamics. Nature 2000, 497:507-511.
128. Miralles F., Posern G., Zaromytidou A.-I., Treisman R. Actin dynamics control SRF activity by regulation of its coactivator MAL. Cell 2003, 113:329-342.
129. Mouilleron S., Guettler S., Langer C.A., Treisman R., McDonald N.Q. Molecular basis for G-actin binding to RPEL motifs from the serum response factor coactivator MAL. EMBO J 2008, 27:3198-3208.
130. Lombardi M.L., Lammerding J. Keeping the LINC: the importance of nucleocytoskeletal coupling in intracellular force transmission and cellular function. Biochem Soc Trans 2011, 39:1729-1734.
131. Méjat A., Misteli T. LINC complexes in health and disease. Nucleus (Austin, TX) 2010, 1:40-52.
132. McGee M.D., Stagljar I., Starr D.A. KDP-1 is a nuclear envelope KASH protein required for cell-cycle progression. J Cell Sci 2009, 122:2895-2905.
133. Zhen Y.-Y., Libotte T., Munck M., Noegel A.A., Korenbaum E. NUANCE, a giant protein connecting the nucleus and actin cytoskeleton. J Cell Sci 2002, 115:3207-3222.
134. King M.C., Drivas T.G., Blobel G. A network of nuclear envelope membrane proteins linking centromeres to microtubules. Cell 2008, 134:427-438.
135. Warren D.T., Zhang Q., Weissberg P.L., Shanahan C.M. Nesprins: intracellular scaffolds that maintain cell architecture and coordinate cell function?. Expert Rev Mol Med 2005, 7:1-15.
136. Zhang Q., Ragnauth C., Greener M.J., Shanahan C.M., Roberts R.G. The nesprins are giant actin-binding proteins, orthologous to Drosophila melanogaster muscle protein MSP-300. Genomics 2002, 80:473-481.
137. Padmakumar V.C., Libotte T., Lu W., Zaim H., Abraham S., Noegel A.A., et al. The inner nuclear membrane protein Sun1 mediates the anchorage of Nesprin-2 to the nuclear envelope. J Cell Sci 2005, 118:3419-3430.
138. Haque F., Lloyd D.J., Smallwood D.T., Dent C.L., Shanahan C.M., Fry A.M., et al. SUN1 interacts with nuclear lamin A and cytoplasmic nesprins to provide a physical connection between the nuclear lamina and the cytoskeleton. Mol Cell Biol 2006, 26:3738-3751.
139. Malone C.J., Misner L., Le Bot N., Tsai M.-C., Campbell J.M., Ahringer J., et al. The C. elegans hook protein, ZYG-12, mediates the essential attachment between the centrosome and nucleus. Cell 2003, 115:825-836.
140. McGee M.D., Rillo R., Anderson A.S., Starr D.A. UNC-83 IS a KASH protein required for nuclear migration and is recruited to the outer nuclear membrane by a physical interaction with the SUN protein UNC-84. Mol Biol Cell 2006, 17:1790-1801.
141. Crisp M., Liu Q., Roux K., Rattner J.B., Shanahan C., Burke B., et al. Coupling of the nucleus and cytoplasm: role of the LINC complex. J Cell Biol 2006, 172:41-53.
142. Maniotis A.J., Bojanowski K., Ingber D.E. Mechanical continuity and reversible chromosome disassembly within intact genomes removed from living cells. J Cell Biochem 1997, 65:114-130.
143. Wang N., Tytell J.D., Ingber D.E. Mechanotransduction at a distance: mechanically coupling the extracellular matrix with the nucleus. Nat Rev Mol Cell Biol 2009, 10:75-82.
144. Mislow J.M.K., Holaska J.M., Kim M.S., Lee K.K., Segura-Totten M., Wilson K.L., et al. Nesprin-1alpha self-associates and binds directly to emerin and lamin A in vitro. FEBS Lett 2002, 525:135-140.
145. Haque F., Mazzeo D., Patel J.T., Smallwood D.T., Ellis J.A., Shanahan C.M., et al. Mammalian SUN protein interaction networks at the inner nuclear membrane and their role in laminopathy disease processes. J Biol Chem 2010, 285:3487-3498.
146. Muntoni F., Bonne G., Goldfarb L.G., Mercuri E., Piercy R.J., Burke M., et al. Disease severity in dominant Emery Dreifuss is increased by mutations in both emerin and desmin proteins. Brain 2006, 129:1260-1268.
147. Wilson K.L., Foisner R. Lamin-binding proteins. Cold Spring Harb Perspect Biol 2010, 2:a000554.
148. Wu X., Yoo Y., Okuhama N.N., Tucker P.W., Liu G., Guan J.-L. Regulation of RNA-polymerase-II-dependent transcription by N-WASP and its nuclear-binding partners. Nat Cell Biol 2006, 8:756-763.
149. Yoo Y., Wu X., Guan J.-L. A novel role of the actin-nucleating Arp2/3 complex in the regulation of RNA polymerase II-dependent transcription. J Biol Chem 2007, 282:7616-7623.
150. Miki T., Okawa K., Sekimoto T., Yoneda Y., Watanabe S., Ishizaki T., et al. mDia2 shuttles between the nucleus and the cytoplasm through the importin-{alpha}/{beta}- and CRM1-mediated nuclear transport mechanism. J Biol Chem 2009, 284:5753-5762.
151. Zuchero J.B., Coutts A.S., Quinlan M.E., Thangue N.B.L., Mullins R.D. p53-cofactor JMY is a multifunctional actin nucleation factor. Nat Cell Biol 2009, 11:451-459.
152. Parfenov V.N., Davis D.S., Pochukalina G.N., Sample C.E., Bugaeva E.A., Murti K.G. Nuclear actin filaments and their topological changes in frog oocytes. Exp Cell Res 1995, 217:385-394.
153. Samwer M., Dehne H.-J., Spira F., Kollmar M., Gerlich D.W., Urlaub H., et al. The nuclear F-actin interactome of Xenopus oocytes reveals an actin-bundling kinesin that is essential for meiotic cytokinesis. EMBO J 2013, 32:1886-1902.
154. Miyamoto K., Pasque V., Jullien J., Gurdon J.B. Nuclear actin polymerization is required for transcriptional reprogramming of Oct4 by oocytes. Genes Dev 2011, 25:946-958.
155. Pederson T., Aebi U. Actin in the nucleus: what form and what for?. J Struct Biol 2002, 140:3-9.
156. de Lanerolle P. Nuclear actin and myosins at a glance. J Cell Sci 2012, 125:4945-4949.
157. Kiseleva E., Drummond S.P., Goldberg M.W., Rutherford S.A., Allen T.D., Wilson K.L. Actin- and protein-4.1-containing filaments link nuclear pore complexes to subnuclear organelles in Xenopus oocyte nuclei. J Cell Sci 2004, 117:2481-2490.
158. Holaska J.M., Kowalski A.K., Wilson K.L. Emerin caps the pointed end of actin filaments: evidence for an actin cortical network at the nuclear inner membrane. PLoS Biol 2004, 2:E231.
159. Ohanian V., Wolfe L.C., John K.M., Pinder J.C., Lux S.E., Gratzer W.B. Analysis of the ternary interaction of the red cell membrane skeletal proteins spectrin, actin, and 4.1. Biochemistry 1984, 23:4416-4420.
160. Krauss S.W. Nuclear actin and protein 4.1: essential interactions during nuclear assembly in vitro. Proc Natl Acad Sci USA 2003, 100:10752-10757.
161. Krauss S.W., Spence J.R., Bahmanyar S., Barth A.I.M., Go M.M., Czerwinski D., et al. Downregulation of protein 4.1R, a mature centriole protein, disrupts centrosomes, alters cell cycle progression, and perturbs mitotic spindles and anaphase. Mol Cell Biol 2008, 28:2283-2294.
162. Meyer A.J., Almendrala D.K., Go M.M., Krauss S.W. Structural protein 4.1R is integrally involved in nuclear envelope protein localization, centrosome-nucleus association and transcriptional signaling. J Cell Sci 2011, 124:1433-1444.
163. Meaburn K.J., Cabuy E., Bonne G., Levy N., Morris G.E., Novelli G., et al. Primary laminopathy fibroblasts display altered genome organization and apoptosis. Aging Cell 2007, 6:139-153.
164. Mewborn S.K., Puckelwartz M.J., Abuisneineh F., Fahrenbach J.P., Zhang Y., Macleod H., et al. Altered chromosomal positioning, compaction, and gene expression with a lamin A/C gene mutation. PLoS ONE 2010, 5:e14342.
165. Ognibene A., Sabatelli P., Petrini S., Squarzoni S., Riccio M., Santi S., et al. Nuclear changes in a case of X-linked Emery-Dreifuss muscular dystrophy. Muscle Nerve 1999, 22:864-869.
166. Demmerle J., Koch A.J., Holaska J.M. The nuclear envelope protein emerin binds directly to histone deacetylase 3 (HDAC3) and activates HDAC3 activity. J Biol Chem 2012, 287:22080-22088.
167. Van de Vosse D.W., Wan Y., Wozniak R.W., Aitchison J.D. Role of the nuclear envelope in genome organization and gene expression. Wiley Interdiscip Rev Syst Biol Med 2011, 3:147-166.
168. Reddy K.L., Zullo J.M., Bertolino E., Singh H. Transcriptional repression mediated by repositioning of genes to the nuclear lamina. Nature 2008, 452:243-247.
169. Guelen L., Pagie L., Brasset E., Meuleman W., Faza M.B., Talhout W., et al. Domain organization of human chromosomes revealed by mapping of nuclear lamina interactions. Nature 2008, 453:948-951.
170. Pickersgill H., Kalverda B., de Wit E., Talhout W., Fornerod M., van Steensel B. Characterization of the Drosophila melanogaster genome at the nuclear lamina. Nat Genet 2006, 38:1005-1014.
171. Shevelyov Y.Y., Lavrov S.A., Mikhaylova L.M., Nurminsky I.D., Kulathinal R.J., Egorova K.S., et al. The B-type lamin is required for somatic repression of testis-specific gene clusters. Proc Natl Acad Sci USA 2009, 106:3282-3287.
172. Finlan L.E., Sproul D., Thomson I., Boyle S., Kerr E., Perry P., et al. Recruitment to the nuclear periphery can alter expression of genes in human cells. PLoS Genet 2008, 4:e1000039.
173. Kumaran R.I., Spector D.L. A genetic locus targeted to the nuclear periphery in living cells maintains its transcriptional competence. J Cell Biol 2008, 180:51-65.
174. Zullo J.M., Demarco I.A., Piqué-Regi R., Gaffney D.J., Epstein C.B., Spooner C.J., et al. DNA sequence-dependent compartmentalization and silencing of chromatin at the nuclear lamina. Cell 2012, 149:1474-1487.
175. Ikegami K., Egelhofer T.A., Strome S., Lieb J.D. Caenorhabditis elegans chromosome arms are anchored to the nuclear membrane via discontinuous association with LEM-2. Genome Biol 2010, 11:R120.
176. Peric-Hupkes D., Meuleman W., Pagie L., Bruggeman S.W.M., Solovei I., Brugman W., et al. Molecular maps of the reorganization of genome-nuclear lamina interactions during differentiation. Mol Cell 2010, 38:603-613.
177. Mehta I.S., Amira M., Harvey A.J., Bridger J.M. Rapid chromosome territory relocation by nuclear motor activity in response to serum removal in primary human fibroblasts. Genome Biol 2010, 11:R5.
178. Meuleman W., Peric-Hupkes D., Kind J., Beaudry J.-B., Pagie L., Kellis M., et al. Constitutive nuclear lamina-genome interactions are highly conserved and associated with A/T-rich sequence. Genome Res 2012, 23:270-280.
179. Kind J., van Steensel B. Genome-nuclear lamina interactions and gene regulation. Curr Opin Cell Biol 2010, 22:320-325.
180. Brill L.M., Salomon A.R., Ficarro S.B., Mukherji M., Stettler-Gill M., Peters E.C. Robust phosphoproteomic profiling of tyrosine phosphorylation sites from human T cells using immobilized metal affinity chromatography and tandem mass spectrometry. Anal Chem 2004, 76:2763-2772.
181. Amanchy R., Kalume D.E., Iwahori A., Zhong J., Pandey A. Phosphoproteome analysis of HeLa cells using stable isotope labeling with amino acids in cell culture (SILAC). J Proteome Res 2005, 4:1661-1671.
182. Tao W.A., Wollscheid B., O'Brien R., Eng J.K., Li X.-J., Bodenmiller B., et al. Quantitative phosphoproteome analysis using a dendrimer conjugation chemistry and tandem mass spectrometry. Nat Methods 2005, 2:591-598.
183. Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P., et al. Global, in vivo, and site-specific phosphorylation dynamics in signaling networks. Cell 2006, 127:635-648.
184. Roberts R.C., Sutherland-Smith A.J., Wheeler M.A., Norregaard Jensen O., Emerson L.J., Spiliotis I.I., et al. The Emery-Dreifuss muscular dystrophy associated-protein emerin is phosphorylated on serine 49 by protein kinase A. FASEB J 2006, 273:4562-4575.
185. Cantin G.T., Yi W., Lu B., Park S.K., Xu T., Lee J.-D., et al. Combining protein-based IMAC, peptide-based IMAC, and MudPIT for efficient phosphoproteomic analysis. J Proteome Res 2008, 7:1346-1351.
186. Pan C., Olsen J.V., Daub H., Mann M. Global effects of kinase inhibitors on signaling networks revealed by quantitative phosphoproteomics. Mol Cell Proteomics 2009, 8:2796-2808.
187. Tsai C.-F., Wang Y.-T., Chen Y.-R., Lai C.-Y., Lin P.-Y., Pan K.-T., et al. Immobilized metal affinity chromatography revisited: pH/acid control toward high selectivity in phosphoproteomics. J Proteome Res 2008, 7:4058-4069.
188. Tifft K.E., Bradbury K.A., Wilson K.L. Tyrosine phosphorylation of nuclear-membrane protein emerin by Src, Abl and other kinases. J Cell Sci 2009, 122:3780-3790.
189. Boersema P.J., Foong L.Y., Ding V.M.Y., Lemeer S., van Breukelen B., Philp R., et al. In-depth qualitative and quantitative profiling of tyrosine phosphorylation using a combination of phosphopeptide immunoaffinity purification and stable isotope dimethyl labeling. Mol Cell Proteomics 2010, 9:84-99.
190. Sui S., Wang J., Yang B., Song L., Zhang J., Chen M., et al. Phosphoproteome analysis of the human Chang liver cells using SCX and a complementary mass spectrometric strategy. Proteomics 2008, 8:2024-2034.
191. Han G., Ye M., Liu H., Song C., Sun D., Wu Y. Phosphoproteome analysis of human liver tissue by long-gradient nanoflow LC coupled with multiple stage MS analysis. Electrophoresis 2010, 31:1080-1089.
192. Rigbolt K.T.G., Prokhorova T.A., Akimov V., Henningsen J., Johansen P.T., Kratchmarova I., et al. System-wide temporal characterization of the proteome and phosphoproteome of human embryonic stem cell differentiation. Sci Signal 2011, 4:rs3.
193. Hirano Y. Dissociation of emerin from barrier-to-autointegration factor is regulated through mitotic phosphorylation of emerin in a xenopus egg cell-free system. J Biol Chem 2005, 280:39925-39933.
194. Daub H., Olsen J.V., Bairlein M., Gnad F., Oppermann F.S., Körner R., et al. Kinase-selective enrichment enables quantitative phosphoproteomics of the kinome across the cell cycle. Mol Cell 2008, 31:438-448.
195. Dephoure N., Zhou C., Villén J., Beausoleil S.A., Bakalarski C.E., Elledge S.J., et al. A quantitative atlas of mitotic phosphorylation. Proc Natl Acad Sci USA 2008, 105:10762-10767.
196. Malik R., Lenobel R., Santamaria A., Ries A., Nigg E.A., Körner R. Quantitative analysis of the human spindle phosphoproteome at distinct mitotic stages. J Proteome Res 2009, 8:4553-4563.
197. Ge F., Xiao C.-L., Yin X.-F., Lu C.-H., Zeng H.-L., He Q.-Y. Phosphoproteomic analysis of primary human multiple myeloma cells. J Proteomics 2010, 73:1381-1390.
198. Rush J., Moritz A., Lee K.A., Guo A., Goss V.L., Spek E.J., et al. Immunoaffinity profiling of tyrosine phosphorylation in cancer cells. Nat Biotechnol 2005, 23:94-101.
199. Olsen J.V., Vermeulen M., Santamaria A., Kumar C., Miller M.L., Jensen L.J., et al. Quantitative phosphoproteomics reveals widespread full phosphorylation site occupancy during mitosis. Sci Signal 2010, 3:ra3.
200. Wheeler M.A., Warley A., Roberts R.G., Ehler E., Ellis J.A. Identification of an emerin-beta-catenin complex in the heart important for intercalated disc architecture and beta-catenin localisation. Cell Mol Life Sci 2010, 67:781-796.
201. Leach N., Bjerke S.L., Christensen D.K., Bouchard J.M., Mou F., Park R., et al. Emerin is hyperphosphorylated and redistributed in herpes simplex virus type 1-infected cells in a manner dependent on both UL34 and US3. J Virol 2007, 81:10792-10803.
202. Bukong T.N., Hall W.W., Jacqué J.-M. Lentivirus-associated MAPK/ERK2 phosphorylates EMD and regulates infectivity. J Gen Virol 2010, 91:2381-2392.
203. Bose R., Molina H., Patterson A.S., Bitok J.K., Periaswamy B., Bader J.S., et al. Phosphoproteomic analysis of Her2/neu signaling and inhibition. Proc Natl Acad Sci USA 2006, 103:9773-9778.
204. Morris J.B., Hofemeister H., O'Hare P. Herpes simplex virus infection induces phosphorylation and delocalization of emerin, a key inner nuclear membrane protein. J Virol 2007, 81:4429-4437.
205. Lattanzi G., Cenni V., Marmiroli S., Capanni C., Mattioli E., Merlini L., et al. Association of emerin with nuclear and cytoplasmic actin is regulated in differentiating myoblasts. Biochem Biophys Res Commun 2003, 303:764-770.
206. Yip S.C., Cotteret S., Chernoff J. Sumoylated protein tyrosine phosphatase 1B localizes to the inner nuclear membrane and regulates the tyrosine phosphorylation of emerin. J Cell Sci 2012, 125:310-316.
207. Margalit A., Liu J., Fridkin A., Wilson K.L., Gruenbaum Y. A lamin-dependent pathway that regulates nuclear organization, cell cycle progression and germ cell development. Novartis Found Symp 2005, 264:231-240. (discussion 240-5).
208. Stuurman N., Heins S., Aebi U. Nuclear lamins: their structure, assembly, and interactions. J Struct Biol 1998, 122:42-66.
209. Heald R., McKeon F. Mutations of phosphorylation sites in lamin A that prevent nuclear lamina disassembly in mitosis. Cell 1990, 61:579-589.
210. Berk J.M., Maitra S., Dawdy A.W., Shabanowitz J., Hunt D.F., Wilson K.L. O-GlcNAc regulates emerin binding to BAF in a chromatin- and lamin B-enriched niche. J Biol Chem 2013, 288:30192-30209.
211. Zachara N.E. Dynamic O-GlcNAc modification of nucleocytoplasmic proteins in response to stress: a survival response of mammalian cells. J Biol Chem 2004, 279:30133-30142.
212. Zachara N.E., Molina H., Wong K.Y., Pandey A., Hart G.W. The dynamic stress-induced O-GlcNAc-ome highlights functions for O-GlcNAc in regulating DNA damage/repair and other cellular pathways. Amino Acids 2010, 40:793-808.
213. Ranuncolo S.M., Ghosh S., Hanover J.A., Hart G.W., Lewis B.A. Evidence of the involvement of O-GlcNAc-modified human RNA polymerase II CTD in transcription in vitro and in vivo. J Biol Chem 2012, 287:23549-23561.
214. Sakabe K., Wang Z., Hart G.W. Beta-N-acetylglucosamine (O-GlcNAc) is part of the histone code. Proc Natl Acad Sci USA 2010, 107:19915-19920.
215. Hart G.W., Slawson C., Ramirez-Correa G., Lagerlof O. Cross talk between O-GlcNAcylation and phosphorylation: roles in signaling, transcription, and chronic disease. Annu Rev Biochem 2011, 80:825-858.
216. Barkan R., Zahand A.J., Sharabi K., Lamm A.T., Feinstein N., Haithcock E., et al. Ce-emerin and LEM-2: essential roles in Caenorhabditis elegans development, muscle function, and mitosis. Mol Biol Cell 2012, 23:543-552.
217. Liu J., Lee K.K., Segura-Totten M., Neufeld E., Wilson K.L., Gruenbaum Y. MAN1 and emerin have overlapping function(s) essential for chromosome segregation and cell division in Caenorhabditis elegans. Proc Natl Acad Sci USA 2003, 100:4598-4603.
218. Gonzalez Y., Saito A., Sazer S. Fission yeast Lem2 and Man1 perform fundamental functions of the animal cell nuclear lamina. Nucleus (Austin, TX) 2012, 3:60-76.
219. Nili E., Cojocaru G.S., Kalma Y., Ginsberg D., Copeland N.G., Gilbert D.J., et al. Nuclear membrane protein LAP2beta mediates transcriptional repression alone and together with its binding partner GCL (germ-cell-less). J Cell Sci 2001, 114:3297-3307.
220. Foisner R., Gerace L. Integral membrane proteins of the nuclear envelope interact with lamins and chromosomes, and binding is modulated by mitotic phosphorylation. Cell 1993, 73:1267-1279.
221. Furukawa K. LAP2 binding protein 1 (L2BP1/BAF) is a candidate mediator of LAP2-chromatin interaction. J Cell Sci 1999, 112(Pt. 15):2485-2492.
222. Somech R. The nuclear-envelope protein and transcriptional repressor LAP2 interacts with HDAC3 at the nuclear periphery, and induces histone H4 deacetylation. J Cell Sci 2005, 118:4017-4025.
223. Solovei I., Wang A.S., Thanisch K., Schmidt C.S., Krebs S., Zwerger M., et al. LBR and lamin A/C sequentially tether peripheral heterochromatin and inversely regulate differentiation. Cell 2013, 152:584-598.
224. Shin J.-Y., Méndez-López I., Wang Y., Hays A.P., Tanji K., Lefkowitch J.H., et al. Lamina-associated polypeptide-1 interacts with the muscular dystrophy protein emerin and is essential for skeletal muscle maintenance. Dev Cell 2013, 26:591-603.
225. Chen C.-Y., Chi Y.-H., Mutalif R.A., Starost M.F., Myers T.G., Anderson S.A., et al. Accumulation of the inner nuclear envelope protein Sun1 is pathogenic in progeric and dystrophic laminopathies. Cell 2012, 149:565-577.